GR3029283T3 - Method of preparing a radioactive rhenium complex solution. - Google Patents

Method of preparing a radioactive rhenium complex solution.

Info

Publication number
GR3029283T3
GR3029283T3 GR990400363T GR990400363T GR3029283T3 GR 3029283 T3 GR3029283 T3 GR 3029283T3 GR 990400363 T GR990400363 T GR 990400363T GR 990400363 T GR990400363 T GR 990400363T GR 3029283 T3 GR3029283 T3 GR 3029283T3
Authority
GR
Greece
Prior art keywords
alkyl
nz1z2
alkoxy
phenyl
represent
Prior art date
Application number
GR990400363T
Other languages
English (en)
Inventor
Andre Bachy
Laurent Fraisse
Peter Keane
Etienne Mendes
Jean-Claude Vernieres
Jacques Simiand
Original Assignee
Sanofi Elf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Elf filed Critical Sanofi Elf
Publication of GR3029283T3 publication Critical patent/GR3029283T3/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Toys (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
GR990400363T 1992-08-27 1999-02-03 Method of preparing a radioactive rhenium complex solution. GR3029283T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9210329A FR2695126B1 (fr) 1992-08-27 1992-08-27 Dérivés d'acide thiényl ou pyrrolyl carboxyliques, leur préparation et médicaments les contenant.

Publications (1)

Publication Number Publication Date
GR3029283T3 true GR3029283T3 (en) 1999-05-28

Family

ID=9433050

Family Applications (1)

Application Number Title Priority Date Filing Date
GR990400363T GR3029283T3 (en) 1992-08-27 1999-02-03 Method of preparing a radioactive rhenium complex solution.

Country Status (17)

Country Link
US (2) US5360799A (el)
EP (1) EP0587473B1 (el)
JP (1) JPH06184145A (el)
KR (1) KR100267802B1 (el)
AT (1) ATE173258T1 (el)
AU (1) AU659027B2 (el)
CA (1) CA2104883A1 (el)
DE (1) DE69322033T2 (el)
DK (1) DK0587473T3 (el)
ES (1) ES2125315T3 (el)
FI (1) FI103889B (el)
FR (1) FR2695126B1 (el)
GR (1) GR3029283T3 (el)
HU (1) HU217623B (el)
MX (1) MX9305181A (el)
NO (1) NO300845B1 (el)
NZ (1) NZ248498A (el)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003256650A1 (en) * 2002-07-19 2004-02-09 Pharmacia Corporation Substituted thiophene carboxamide compounds for the treatment of inflammation
GB0522715D0 (en) 2005-11-08 2005-12-14 Helperby Therapeutics Ltd New use
CN103214483B (zh) 2005-12-13 2014-12-17 因塞特公司 作为两面神激酶抑制剂的杂芳基取代的吡咯并[2,3-b]吡啶和吡咯并[2,3-b]嘧啶
CN101679357A (zh) * 2007-05-09 2010-03-24 辉瑞大药厂 取代的杂环衍生物及其组合物和作为抗菌剂的药物用途
WO2008154447A1 (en) * 2007-06-08 2008-12-18 Helicon Therapeutics, Inc. Therapeutic pyrazolonaphthyridine derivatives
WO2009027393A2 (en) 2007-08-27 2009-03-05 Basf Se Pyrazole compounds for controlling invertebrate pests
JP4719317B2 (ja) * 2008-02-26 2011-07-06 武田薬品工業株式会社 縮合複素環誘導体およびその用途
AU2009295936B2 (en) 2008-09-24 2014-07-17 Basf Se Pyrazole compounds for controlling invertebrate pests
BRPI1012159B1 (pt) 2009-05-22 2022-01-25 Incyte Holdings Corporation Compostos derivados de n-(hetero)aril-pirrolidina de pirazol-4-il-pirrolo[2,3-d] pirimidinas e pirrol-3-il-pirrolo[2,3-d] pirimidinas como inibidores de janus cinase, composições farmacêuticas compreendendo os referidos compostos e usos dos mesmos
DK2432472T3 (da) 2009-05-22 2019-11-18 Incyte Holdings Corp 3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl]octan- eller heptan-nitril som jak-inhibitorer
EP2451804B1 (en) 2009-07-06 2014-04-30 Basf Se Pyridazine compounds for controlling invertebrate pests
WO2011009804A2 (en) 2009-07-24 2011-01-27 Basf Se Pyridine derivatives compounds for controlling invertebrate pests
TW201113285A (en) 2009-09-01 2011-04-16 Incyte Corp Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
KR102283091B1 (ko) 2010-03-10 2021-07-30 인사이트 홀딩스 코포레이션 Jak1 저해제로서의 피페리딘­4­일 아제티딘 유도체
AR083933A1 (es) 2010-11-19 2013-04-10 Incyte Corp Derivados de pirrolopiridina y pirrolopirimidina sustituidos con ciclobutilo como inhibidores de jak
CN103797010B (zh) 2011-06-20 2016-02-24 因塞特控股公司 作为jak抑制剂的氮杂环丁烷基苯基、吡啶基或吡嗪基甲酰胺衍生物
TW201313721A (zh) 2011-08-18 2013-04-01 Incyte Corp 作為jak抑制劑之環己基氮雜環丁烷衍生物
UA111854C2 (uk) 2011-09-07 2016-06-24 Інсайт Холдінгс Корпорейшн Способи і проміжні сполуки для отримання інгібіторів jak
US9193733B2 (en) 2012-05-18 2015-11-24 Incyte Holdings Corporation Piperidinylcyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitors
SG10201703533VA (en) 2012-11-01 2017-06-29 Incyte Corp Tricyclic fused thiophene derivatives as jak inhibitors
CR20190073A (es) 2012-11-15 2019-04-25 Incyte Holdings Corp FORMAS DE DOSIFICACIÓN DE RUXOLITINIB DE LIBERACIÓN SOTENIDA (Divisional 2015-265)
RS62867B1 (sr) 2013-03-06 2022-02-28 Incyte Holdings Corp Postupci i intermedijeri za dobijanje inhibitora jak
EP3030227B1 (en) 2013-08-07 2020-04-08 Incyte Corporation Sustained release dosage forms for a jak1 inhibitor
CA2947418A1 (en) 2014-04-30 2015-11-05 Incyte Corporation Processes of preparing a jak1 inhibitor and new forms thereto
US9498467B2 (en) 2014-05-30 2016-11-22 Incyte Corporation Treatment of chronic neutrophilic leukemia (CNL) and atypical chronic myeloid leukemia (aCML) by inhibitors of JAK1
JP2018537450A (ja) 2015-11-16 2018-12-20 ファンダシオン パラ ラ インベスティガシオン メディカ アプリカダFundacion Para La Investigasion Medica Aplicada Dnaメチルトランスフェラーゼ阻害剤としての新規化合物
JP2021519775A (ja) 2018-03-30 2021-08-12 インサイト・コーポレイションIncyte Corporation Jak阻害剤を用いる化膿性汗腺炎の治療
US11833155B2 (en) 2020-06-03 2023-12-05 Incyte Corporation Combination therapy for treatment of myeloproliferative neoplasms
AU2022367432A1 (en) 2021-10-14 2024-05-02 Incyte Corporation Quinoline compounds as inhibitors of kras
US11897883B1 (en) 2023-09-01 2024-02-13 King Faisal University Pyrrolo[3,2-c][1,6]naphthyridine-2-carboxylic acid compounds as CK2 inhibitors
US11891377B1 (en) 2023-09-06 2024-02-06 King Faisal University Pyrrolo[3,2-c][2,7]naphthyridine-2-carboxylic acid compounds as CK2 inhibitors
US11866437B1 (en) 2023-09-15 2024-01-09 King Faisal University 1,2-dioxo-2,3-dihydro-1H-pyrrolo[2,3-c]quinoline-7-carboxylic acid compounds as CK2 inhibitors
US11952378B1 (en) 2023-12-14 2024-04-09 King Faisal University Pyrrolo[2,3-c]isoquinoline-1,2-dione compounds as CK2 inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3887570A (en) * 1973-09-28 1975-06-03 Squibb & Sons Inc Derivatives of pyrazolo(3,4-b)thieno(2,3-d)pyridine-2-carboxylic acids

Also Published As

Publication number Publication date
NO933051L (no) 1994-02-28
JPH06184145A (ja) 1994-07-05
US5360799A (en) 1994-11-01
FR2695126A1 (fr) 1994-03-04
DE69322033D1 (de) 1998-12-17
NO933051D0 (no) 1993-08-26
KR100267802B1 (ko) 2000-11-01
CA2104883A1 (fr) 1994-02-28
KR940003958A (ko) 1994-03-14
FR2695126B1 (fr) 1994-11-10
HUT64957A (en) 1994-03-28
FI933756A0 (fi) 1993-08-26
US5468750A (en) 1995-11-21
EP0587473B1 (fr) 1998-11-11
HU9302425D0 (en) 1993-11-29
FI933756A (fi) 1994-02-28
NZ248498A (en) 1994-09-27
AU659027B2 (en) 1995-05-04
AU4474793A (en) 1994-03-03
DE69322033T2 (de) 1999-06-17
MX9305181A (es) 1994-06-30
FI103889B1 (fi) 1999-10-15
FI103889B (fi) 1999-10-15
EP0587473A1 (fr) 1994-03-16
DK0587473T3 (da) 1999-07-26
ATE173258T1 (de) 1998-11-15
HU217623B (hu) 2000-03-28
NO300845B1 (no) 1997-08-04
ES2125315T3 (es) 1999-03-01

Similar Documents

Publication Publication Date Title
GR3029283T3 (en) Method of preparing a radioactive rhenium complex solution.
ES8407025A1 (es) Un procedimiento para preparar derivados de nicotinamida.
EP0040639A4 (en) ISOXAZOLE DERIVATIVES.
ES8500239A1 (es) Procedimiento para preparar derivados de triazol e imidazol.
ES8107142A1 (es) Un procedimiento para la preparacion de acetofenonas substi-tuidas
NO923126D0 (no) Preparat og metode for behandling av canser
AU603232B2 (en) Herbicidal agents
PT75105A (en) Process for preparing herbicidal compositions containing heterocyclic pentalenes
IL101379A0 (en) Light screening compositions containing isoxazolones,certain such novel compounds and their preparation
JPS5553206A (en) Agent for controlling leafhopper and planthopper
GB1081635A (en) Novel amines and a process for the preparation thereof
GB1526938A (en) Derivatives of n-phenyl-n-aroylalanine and herbicidal compositions containing them
GR3004231T3 (el)
JPS52100466A (en) Preparation of 5-oxo-2-(beta-haloethyl)pyrrlidines
JPS5315329A (en) Phenoxyphenoxypropionic acid derivatives and herbicides containing same
MY104164A (en) Heterocyclic compounds.
ES8201587A1 (es) Procedimiento de producir compuestos cefalosporinicos anti- microbianos
JPS51128988A (en) Process for preparing quinazolone compounds